Trials / Unknown
UnknownNCT00692718
N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Osaka General Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Our study is to investigate the effect of N-3 Fatty Acids for the prevention of atrial fibrillation in patients with acute heart failure or acute myocardial infarction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epadel, Eicosapentaenoic acid | Epadel 900mg, 2 times a day, during hospitalization |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2010-06-01
- First posted
- 2008-06-06
- Last updated
- 2008-06-19
Source: ClinicalTrials.gov record NCT00692718. Inclusion in this directory is not an endorsement.